These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 8517917)
1. Can AIDS be prevented by T-cell vaccination? Atlan H; Gersten MJ; Salk PL; Salk J Immunol Today; 1993 May; 14(5):200-2. PubMed ID: 8517917 [TBL] [Abstract][Full Text] [Related]
2. A strategy for prophylactic vaccination against HIV. Salk J; Bretscher PA; Salk PL; Clerici M; Shearer GM Science; 1993 May; 260(5112):1270-2. PubMed ID: 8098553 [No Abstract] [Full Text] [Related]
3. T-cell strategies in AIDS vaccines: MHC-restricted T-cell responses to HIV proteins. Mills KH; Nixon DF; McMichael AJ AIDS; 1989; 3 Suppl 1():S101-10. PubMed ID: 2575396 [No Abstract] [Full Text] [Related]
4. Protection from HIV infection or AIDS? Miedema F; Meyaard L; Klein MR Science; 1993 Nov; 262(5136):1074-6. PubMed ID: 8235627 [No Abstract] [Full Text] [Related]
5. T cell regulation of collagen-induced arthritis in mice. II. Immunomodulation of arthritis by cytotoxic T cell hybridomas specific for type II collagen. Chiocchia G; Boissier MC; Manoury B; Fournier C Eur J Immunol; 1993 Feb; 23(2):327-32. PubMed ID: 8436167 [TBL] [Abstract][Full Text] [Related]
6. Update on vaccine development in AIDS and cancer. MacDougall DS J Int Assoc Physicians AIDS Care; 1995 Apr; 1(3):18-24. PubMed ID: 11362485 [TBL] [Abstract][Full Text] [Related]
7. Cytotoxic T cells--protection from disease progression--protection from infection. Gotch F; Gallimore A; McMichael A Immunol Lett; 1996 Jun; 51(1-2):125-8. PubMed ID: 8811356 [TBL] [Abstract][Full Text] [Related]
8. Cytotoxic T lymphocytes in HIV-induced disease: implications for therapy and vaccination. Plata F; Dadaglio G; Chenciner N; Hoffenbach A; Wain-Hobson S; Michel F; Langlade-Demoyen P Immunodefic Rev; 1989; 1(3):227-46. PubMed ID: 2698642 [TBL] [Abstract][Full Text] [Related]
9. [Development of HIV vaccines]. Shibata R Nihon Rinsho; 2002 Apr; 60(4):790-7. PubMed ID: 11968790 [TBL] [Abstract][Full Text] [Related]
10. Cytotoxic T lymphocytes in AIDS pathogenesis: lessons to be learned from the macaque model of simian immunodeficiency virus infection. Geretti AM; Hulskotte E; Osterhaus AD J Gen Virol; 1998 Mar; 79 ( Pt 3)():415-21. PubMed ID: 9519818 [No Abstract] [Full Text] [Related]
11. Mucosal immunity, HIV transmission, and AIDS. Miller CJ; McGhee JR; Gardner MB Lab Invest; 1993 Feb; 68(2):129-45. PubMed ID: 8441249 [No Abstract] [Full Text] [Related]
12. HIV-specific cytotoxic T lymphocytes and their possible implications in the future vaccine against AIDS. Langlade-Demoyen P; Hoffenbach A Res Immunol; 1989 Jan; 140(1):95-9; discussion 119-20. PubMed ID: 2567045 [No Abstract] [Full Text] [Related]
13. Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model. Nehete PN; Chitta S; Hossain MM; Hill L; Bernacky BJ; Baze W; Arlinghaus RB; Sastry KJ Vaccine; 2001 Dec; 20(5-6):813-25. PubMed ID: 11738745 [TBL] [Abstract][Full Text] [Related]
14. The value of preserving HIV-specific immune responses. Kaufmann DE; Rosenberg ES J HIV Ther; 2003 Feb; 8(1):19-25. PubMed ID: 12840711 [TBL] [Abstract][Full Text] [Related]
15. Vaccination with Rev and Tat against AIDS. Osterhaus AD; van Baalen CA; Gruters RA; Schutten M; Siebelink CH; Hulskotte EG; Tijhaar EJ; Randall RE; van Amerongen G; Fleuchaus A; Erfle V; Sutter G Vaccine; 1999 Jun; 17(20-21):2713-4. PubMed ID: 10418922 [No Abstract] [Full Text] [Related]
16. Development of prophylactic AIDS vaccines: the current state of affairs. Hanke T Curr Opin Mol Ther; 2003 Feb; 5(1):25-32. PubMed ID: 12669467 [TBL] [Abstract][Full Text] [Related]
17. Preventing AIDS but not HIV-1 infection with a DNA vaccine. Shen X; Siliciano RF Science; 2000 Oct; 290(5491):463-5. PubMed ID: 11183769 [TBL] [Abstract][Full Text] [Related]